Thomas Catinazzo, Chief Financial Officer at Relay Therapeutics, Inc. (RLAY), sold 15,515 shares at $7.62 ($120K) on 2026-01-27, disclosed to the SEC on 2026-01-29.
Seasonal sale ($120k) by Chief Financial Officer — this insider has traded RLAY in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.62 | 13,820 | $105K | 88.0% |
| 2 | $8.45 | 1,695 | $14K | 12.0% |
| Total | $7.71 avg | 15,515 | $120K | 100% |
| Filing → |
| RLAY | SELL | 2026-08-18 | $350K | — | Filing → |
| RLAY | SELL | 2026-07-30 | $27K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $331K | — | Filing → |